Allergic Disease on the Rise
Increasing rate of allergic asthma looked at by McGill researchers, including Dr. Irah King.
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
Increasing rate of allergic asthma looked at by McGill researchers, including Dr. Irah King.
MUHC Foundation Health Matters interview with Benjamin Smith on the ideal COVID-19 testing strategy to shorten isolation time for health care workers
Dr. Nicole Ezer, of the RI-MUHC’s RESP Program, discusses COVID-19 treatment options on Radio-Canada.
Dr. Sushmita Pamidi’s new study examines the impact of sleep apnea treatment on heart health
Dr. Jean Bourbeau’s opinion piece in the Star highlights how various treatment options against COVID-19 are needed
MUHC Foundation Health Matters interview with Dick Menzies discusses how improved testing is the needed to contain the second wave of the COVID-19 pandemic
MUHC Foundation Health Matters interview with Jean Bourbeau discusses a new clinical trial for patients at risk of severe COVID-19 complications
Drs. Nicole Ezer, James Martin, Ben Smith, Andrea Benedetti and colleagues initiate ciclesonide clinical trial for COVID-19
Congratulations to Sabah Hussain, Kevin Schwartzman, and Jean Bourbeau on their CIHR Projects Grants!
Dr. Jean Bourbeau speaks to the impact of poor air quality caused by wildfire smoke currently blanketing parts of BC